SDC2 and colorectal carcinoma: In this study, we evaluated the performance of a new blood-based early CRC screening assay (ColoDefense), which combined the detection of SEPT9 and SDC2 methylations in a single qPCR reaction, with the remaining serum samples after the blood biochemical test.